Posters

Posterior chamber phakic intraocular lens for hyperopia between years 2006 – 2015

Poster Details

First Author: s. soria ARGENTINA

Co Author(s):    A. Chialvo   M. Canepa   P. Coccaro   P. Güereña   A. Bejarsky   N. Feola     

Abstract Details

Purpose:

to asses the clinical outcomes of implantable collamer lens (vision icl; staar surgical) implantation for hyperopia between years 2006-2015

Setting:

Clinica Privada de Ojos, Mar del Plata, Buenos Aires, Argentina

Methods:

43 eyes of 24 patients with hyperopia had implantation of an ICL between the years 2006 and 2015. 5 patients had implantation in one eye and 19 in both eyes. Patients were examined preoperatively and 1 day, 10 days, 1 month and 1 year postoperatively. Main outcome measures were subjective and objective refractions, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), endothelial cells count, adverse efects and cataract formation

Results:

The mean MD preoperatory spherical refraction was + 3,72 +/- 1,43 SD, (range + 1,25 to + 7,25). Mean cylinder was + 1,1 +/- 1,08 SD (range 0 to 0,9 logMAR). Mean endothelial cells count were 2701, 17 +/- 326, 71 (range 2079 to 3354). All surgerys were uneventful. One year postoperatory, mean uncorrected visual acuity was 0,17 logMAR +/- 0,18 logMAR (range 0 to 0,7). BCVA was 0,14 logMAR +/- 0,17 logMAR SD (range 0 to 0,6). Refraction was 0,15 +/- 0,36 (range -0,75 to +1). Mean endothelial cells count was 2613,25 +/- 308, 93 (range 2034 to 3165). There was no cataract formation

Conclusions:

Posterior chamber phakic intraocular lens (ICL) implantation is safe and effective in the treatment of hyperopia

Financial Disclosure:

NONE